In addition, it raises execution chance mainly because new builds must recruit and train scarce process engineers. If FDA anticipations tighten for knowledge integrity, Merck's scale and good quality techniques must assist shield continuity. A draw back circumstance is slower ramp timing that forces larger dependence on exterior drug compound compa